PAK1 and hepatocellular carcinoma: Taken together, these results indicated that IPA-3 treatment suppressed HCC cell proliferation in a descending order of preference, metastatic HCC >primary HCC>non-transformed hepatocytes, and in a PAK1-dependent manner.